Literature DB >> 17300678

Ovarian cancer incidence and survival in Korea: 1993-2002.

H H Chung1, S Y Hwang, K W Jung, Y J Won, H R Shin, J W Kim, H P Lee.   

Abstract

This study examined incidence rates, histologic and stage distribution, and long-term survival rates of patients with ovarian cancer in Korea. A total of 11,404 patients diagnosed with ovarian cancer between 1993 and 2002 were reported to the Korea Central Cancer Registry and the Gynecologic Oncology Committee of Korean Society of Obstetrics and Gynecology. All rates were expressed per 100,000. The age-standardized incidence rates were 3.79 and 4.74 per 100,000 women in 1993 and 2002, respectively. The incidence rates of ovary cancer increased with age in Korea, and over half of the patients were in the stage IA (24.8%) and IIIC (26.8%) in this study. The 5-year relative survival rate was 59.6%. Relative survivals according to the stage of FIGO at 5 years were 91.1%, 75.2%, 46.4%, and 21.2% for stages I, II, III, and IV, respectively. The 5-year relative survivals of germ cell tumors and epithelial ovarian cancer were 89.0% and 58.3%, respectively. Surgical stage and histology were the most important prognostic factors of ovarian cancer. However, the 5-year survival rate of FIGO stage IC was significantly higher than that of stage IB.

Entities:  

Mesh:

Year:  2007        PMID: 17300678     DOI: 10.1111/j.1525-1438.2007.00824.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  9 in total

1.  The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry.

Authors:  Hyeong In Ha; Ha Kyun Chang; Soo Jin Park; Jiwon Lim; Young-Joo Won; Myong Cheol Lim
Journal:  Obstet Gynecol Sci       Date:  2021-08-17

2.  Feasibility and safety of extensive upper abdominal surgery in elderly patients with advanced epithelial ovarian cancer.

Authors:  Myong Cheol Lim; Sokbom Kang; Yong Jung Song; Sae Hyun Park; Sang-Yoon Park
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

3.  BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.

Authors:  Myong Cheol Lim; Sokbom Kang; Sang-Soo Seo; Sun-Young Kong; Bo-Yon Lee; Seon-Kyung Lee; Sang-Yoon Park
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-05       Impact factor: 4.553

4.  Clinical Efficacy of Ovarian Cancer Screening.

Authors:  Masafumi Koshiyama; Noriomi Matsumura; Ikuo Konishi
Journal:  J Cancer       Date:  2016-06-25       Impact factor: 4.207

5.  Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer.

Authors:  Bihui Huang; Mingzhu Yin; Xia Li; Guosheng Cao; Jin Qi; Ge Lou; Shijie Sheng; Junping Kou; Kang Chen; Boyang Yu
Journal:  Oncotarget       Date:  2016-05-10

Review 6.  Subtypes of Ovarian Cancer and Ovarian Cancer Screening.

Authors:  Masafumi Koshiyama; Noriomi Matsumura; Ikuo Konishi
Journal:  Diagnostics (Basel)       Date:  2017-03-02

7.  Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009.

Authors:  Chang-Mo Oh; Kyu-Won Jung; Young-Joo Won; Aesun Shin; Hyun-Joo Kong; Jae Kwan Jun; Sang-Yoon Park
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

8.  Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010.

Authors:  Myong Cheol Lim; Eun-Kyeong Moon; Aesun Shin; Kyu-Won Jung; Young-Joo Won; Sang Soo Seo; Sokbom Kang; Jae-Weon Kim; Joo-Young Kim; Sang-Yoon Park
Journal:  J Gynecol Oncol       Date:  2013-10-02       Impact factor: 4.401

9.  Temporal Trends of Common Female Malignances on Breast, Cervical, and Ovarian Cancer Mortality in Japan, Republic of Korea, and Singapore: Application of the Age-Period-Cohort Model.

Authors:  Jinyao Wang; Haizhen Lv; Zhilin Xue; Lu Wang; Zhiqiang Bai
Journal:  Biomed Res Int       Date:  2018-03-21       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.